ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 102

$502K Total Retail Price of All Prescriptions

Rank: 36 out of 102

406 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
FUROSEMIDE 711 659 94 1 4
LISINOPRIL 575 570* 87 2 5
METOPROLOL SUCCINATE 551 546* 68 3 8
LEVOTHYROXINE SODIUM 541 505 73 4 1
AMLODIPINE BESYLATE 427 422* 57 5 6
OMEPRAZOLE 409 377 58 6 2
WARFARIN SODIUM 370 350 41 7 7
ATORVASTATIN CALCIUM 348 343* 48 8 11
SIMVASTATIN 328 316 44 9 3
METOPROLOL TARTRATE 304 292 43 10 12
GLIMEPIRIDE 278 273* 39 11 55
KLOR-CON 10 277 251 35 12 59
GABAPENTIN 269 224 31 13 19
LOSARTAN POTASSIUM 206 201* 28 14 10
ATENOLOL 205 205 23 15 16
LOVASTATIN 191 178 27 16 78
HYDROCODONE-ACETAMINOPHEN 176 162 43 S3 17 13
POTASSIUM CHLORIDE 173 143 24 18 9
METFORMIN HCL 156 130 30 19 14
CLOPIDOGREL 155 150* 24 20 20
HYDROCHLOROTHIAZIDE 144 139* 23 21 18
TAMSULOSIN HCL 138 133* 22 22 21
CITALOPRAM HBR 131 126* 19 23 17
LORAZEPAM 131 115 28 B 23 29
MIRTAZAPINE 125 102 17 25 37
ISOSORBIDE MONONITRATE ER 123 123 14 26 39
VENLAFAXINE HCL ER 123 98 14 26 102
ALENDRONATE SODIUM 115 110* 24 28 24
DONEPEZIL HCL 109 109 15 29 27
QUETIAPINE FUMARATE 106 86 12 A 30 68
SERTRALINE HCL 105 75 16 31 23
POLYETHYLENE GLYCOL 3350 104 99* 20 32 33
RESTASIS 93 <11 <11 33 195
INSULIN SYRINGE* 83 83 11 34 130
OLANZAPINE 82 <11 <11 A 35 130
SPIRONOLACTONE 82 64 11 35 32
METFORMIN HCL ER 80 <11 <11 37 77
FLUTICASONE PROPIONATE 77 64 22 38 35
AMITRIPTYLINE HCL 77 <11 <11 R 38 62
ROPINIROLE HCL 77 <11 <11 38 67
ESCITALOPRAM OXALATE 73 <11 <11 41 50
ALLOPURINOL 72 <11 <11 42 25
TRAMADOL HCL 71 71 17 43 15
ENALAPRIL MALEATE 67 <11 <11 44 81
DIGOXIN 62 <11 <11 45 42
RANITIDINE HCL 61 61 13 46 51
ZOLPIDEM TARTRATE 61 <11 <11 46 31
CARVEDILOL 61 61 11 46 22
PAROXETINE HCL 59 <11 <11 49 88
PRAVASTATIN SODIUM 59 54* 11 49 30
FENTANYL 57 <11 <11 S2 51 36
RAMIPRIL 54 <11 <11 52 164
LANTUS 53 <11 <11 53 44
DIGOX 52 <11 <11 54 57
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.